Overview

Procrit Versus Placebo to Determine Efficacy in Pre-Operative Major Surgical Oncology Operations

Status:
Withdrawn
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effectiveness of a two-dose regimen of Procrit prior to a major surgical oncology operation.
Phase:
Phase 2
Details
Lead Sponsor:
University of Louisville
Collaborator:
Ortho Biotech, Inc.
Treatments:
Epoetin Alfa